Q4 2025 Holdings
Filed 2026-02-13 | 66 holdings | $137.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crispr Therapeutics AG(CRSP)Call | NAMEN AKT | H17182108 | $2.6M | 50,000 | 1.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $2.7M | 100,000 | 2.0% |
| Tela BIO Inc(TELA) | COM | 872381108 | $2.8M | 2,352,032 | 2.0% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $2.8M | 339,902 | 2.0% |
| Verrica Pharmaceuticals Inc(VRCA) | COM SHS | 92511W207 | $2.9M | 353,669 | 2.1% |
| Xoma Royalty Corporation(XOMA) | COM NEW | 98419J206 | $3.1M | 115,000 | 2.2% |
| Kazia Therapeutics LTD | SPONSORED ADS | 48669G303 | $3.2M | 460,359 | 2.3% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $3.2M | 389,916 | 2.3% |
| Indivior PLC(INDV) | ORD | G4766E116 | $3.6M | 100,000 | 2.6% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $3.6M | 85,000 | 2.6% |
| Abeona Therapeutics Inc(ABEO) | COM NEW | 00289Y206 | $3.7M | 709,505 | 2.7% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $4.8M | 2,348,147 | 3.5% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $5.1M | 569,088 | 3.7% |
| Evolus Inc(EOLS) | COM | 30052C107 | $10.9M | 1,631,588 | 7.9% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $13.5M | 740,000 | 9.9% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $21.1M | 2,732,079 | 15.4% |